Full Paper
2
2
1H, CHimidazole), 5.75 (d, J(H,H)=14.8 Hz, 1H; CH2), 5.52 (d, J(H,H)=
14.8 Hz, 1H; CH2), 4.69 (s, 2H; CHCOD), 3.96 (s, 3H; CH3), 3.03 (m,
1H; CHCOD), 2.90 (m, 1H; CHCOD), 2.27–2.12 (m, 2H; CH2,COD), 2.12–
1.99 (m, 1H; CH2,COD), 1.82–1.68 (m, 2H; CH2,COD), 1.62 (s, 1H;
CH2,COD), 1.60–1.51 (m, 1H; CH2,COD), 1.43 ppm (m, J=8.5, 5.5 Hz,
1H; CH2,COD). 13C NMR (75 MHz, CDCl3): d=180.9 (IrCcarbene), 136.5
(Cph), 129.0(CHph), 128.4 (CHph), 128.3 (CHph), 122.3 (CHimidazole), 120.2
(CHimidazole), 105.2, 84.5 (CHCOD), 84.2 (CHCOD), 54.21 (CH3), 52.58
(CH2), 52.4 (CH2), 37.6 (CHCOD), 33.8 (CHCOD), 33.2 (CHCOD), 31.1
(CHCOD), 30.2 (CHCOD), 29.7 ppm (CHCOD); elemental analysis calcd
(%) for C19H25N2BrIrH2O (571.5515): C 40.00, H 4.70, N 5.00; found:
C 39.51, H 4.05, N 4.63; ESI-MS (cone 20 V): m/z: 473.63 [MÀBr]+.
fied by column chromatography. The pure compound 8 was
eluted with dichloromethane/ethyl acetate (8:2) and precipitated
in a mixture of dichloromethane/hexane to give a yellow solid.
1
3
Yield 87 mg (66%); H NMR (500 MHz, CDCl3): d=8.50 (d, J(H,H)=
9.2 Hz, 2H; CHpy), 8.29–8.14 (m, 7H; CHpy), 8.06 (m, 9H), 7.58 (d,
3
3J(H,H)=7.9 Hz, 4H; CHPh), 7.47 (d, J(H,H)=7.9 Hz, 4H; CHPh), 6.69–
2
6.54 (m, 4H; CHimidazole, CH2), 6.46 (s, 2H; CHimidazole), 6.17 (t, J(H,H)=
13.3 Hz, 2H; CH2), 5.87 (d, 2J(H,H)=14.9 Hz, 2H; CH2), 5.67 (d,
2J(H,H)=14.7 Hz, 2H; CH2), 4.82 (m, 4H; CHCOD), 3.21 (m, 2H;
CHCOD), 3.09 (m, 2H; CHCOD), 2.35–1.97 (m, 8H; CH2,COD), 1.71 (m,
4H; CH2,COD), 1.37–1.23 (m, 2H; CH2,COD), 0.89 ppm (m, 2H; CH2,COD);
13C NMR (126 MHz, CDCl3): d=180.8 (IrÀCcarbene), 140.4 (Pyr), 135.5
(Pyr), 131.7 (Pyr), 131.2 (Pyr), 130.8 (Pyr), 129.4 (Pyr), 128.8 (Pyr),
128.8 (Pyr), 128.5 (Pyr), 128.0 (Pyr), 127.6(Pyr), 127.5 (Pyr),
127.3(Pyr), 126.2 (Pyr), 125.6 (Pyr), 125.0 (CPh), 124.9 (CPh), 124.6
(CHPh), 123.1 (CHPh), 120.6 (CHimidazole), 120.2 (CHimidazole), 84.8 (CHCOD),
84.7 (CHCOD), 54.1 (CH2), 52.9 (CH2), 52.7 (CHCOD), 52.3 (CHCOD), 33.4
(CH2,COD), 29.7 ppm (CH2,COD); elemental analysis calcd (%) for
C70H64N4Br2Ir2CHCl3 (1622.8877): C 52.55, H 3.91, N 3.45; found: C
52.1, H 3.5, N 3.4, ESI-MS (cone 20 V): m/z: 1464.0 [(M-Br)+MeCN]+.
Synthesis of complex 6: A mixture of 2 (70.0 mg, 0.16 mmol),
[{IrCl(COD) }2] (53.73 mg, 0.08 mmol), K2CO3 (67.0 mg, 0.48 mmol)
and KBr (70 mg) in THF/DMF (7:2 mL) was stirred at 758C for 8 h
under N2. The resulting suspension was cooled to room tempera-
ture and the solvent was removed under vacuum. The pure com-
pound 6 was precipitated in a mixture of dichloromethane/hexane
to give a yellow solid. Yield 65 mg (54%); 1H NMR (300 MHz,
CDCl3): d=8.50 (d, 3J(H,H)=9.2 Hz, 1H; CHpy), 8.31–8.18 (m, 4H;
2
CHpy), 8.08 (m, 4H; CHpy), 7.58–7.32 (m, 5H; CHPh), 6.61 (d, J(H,H)=
Synthesis complex 9: A mixture of 2 (70.0 mg, 0.16 mmol),
[{RhCl(COD)}2] (39.43 mg, 0.08 mmol), K2CO3 (67.0 mg, 0.48 mmol)
and KBr (70 mg) in THF/DMF (7:2 mL) was stirred at 758C for 8 h
under N2. The resulting suspension was cooled to room tempera-
ture and the solvent was removed under vacuum. The pure com-
pound 9 was precipitated in a mixture of dichloromethane/hexane
to give a yellow solid. Yield 60 mg (56%); 1H NMR (300 MHz,
CDCl3): d=8.53 (d, 3J(H,H)=9.3 Hz, 1H; CHpyr), 8.32–8.14 (m, 4H;
CHpyr), 8.06 (m, 4H; CHpyr), 7.37 (m, 5H; CHPh), 6.69 (d, 2J(H,H)=
14.8 Hz, 1H; CH2), 6.59 (d, 2J(H,H)=1.9 Hz, 1H; CH), 6.46 (d,
2J(H,H)=2.0 Hz, 1H; CH), 6.33 (d, 2J(H,H)=14.8 Hz, 1H; CH2), 5.87
(d, 2J(H,H)=2.6 Hz, 2H; CHCOD), 5.23 (s, 2H; CH), 3.58 (m, 1H;
CHCOD), 3.48 (m, 1H; CHCOD), 2.47–2.12 (m, 4H; CH2,COD), 1.89 ppm
14.4 Hz, 2H; CH2, CHimidazole), 6.46 (s, 1H), 6.16 (d, 2J(H,H)=
14.8 Hz,1H; CH2) 5.79 (d, 2J(H,H)=15.0 Hz, 1H: CH2), 5.68 (d,
2J(H,H)=14.8 Hz, 1H; CH2), 4.82 (s, 2H; CHCOD), 3.21 (s, 1H; CHCOD),
3.09 (s, 1H; CHCOD), 2.15 (m, 4H; CH2,COD), 1.6 ppm (m, 4H; CH2,COD),
13C NMR (126 MHz, CDCl3): d=180.9 (IrCcarbene), 136.4 (Pyr), 131.8
(Pyr), 131.3 (Pyr), 130.9 (Pyr), 129.6 (Pyr), 198.0 (Pyr), 128.9 (Pyr),
128.7 (Pyr), 128.4 (Pyr), 128.2 (Pyr), 128.1 (Pyr), 127.7 (Pyr), 127.4
(Pyr), 126.3 (Pyr), 125.7 (Pyr), 125.7 (Pyr), 125.1 (CPh), 125.0 (CHPh),
124.7 (CHPh), 123.2 (CHPh), 120.6 (CHimidazole), 120.3 (CHimidazole), 84.8
(CHCOD), 84.8 (CHCOD), 54.6 (CH2), 53.0 (CH2), 52.7 (CH,COD), 52.4
(CH,COD), 33.4 (CH2,COD), 29.8 ppm (CH2,COD); elemental analysis calcd
(%) for C35H32N2BrIrH2O (770.7783): C 54.74, H 4.44, N 3.50; found:
C 54.53, H 4.44, N 3.63; ESI-MS (cone 20 V): m/z: 671.2[MÀBr]+.
1
(m, 4H; CH2,COD). 13C NMR (75 MHz, CDCl3): d=183.6 (d, J=50 Hz,
RhCcarbene),140.5 (Pyr), 135.9 (Pyr), 131.8(Pyr), 131.4(Pyr), 131.0(Pyr),
129.6 (Pyr), 129.00 (Pyr), 129.0 (Pyr), 128.9 (Pyr), 128.1(Pyr), 127.7
(Pyr), 127.4(Pyr), 126.4(Pyr), 125.8 (Pyr), 125.8 (Pyr), 125.1 (CPh),
125.1 (CPh), 124.7 (CHPh), 123.3 (CHPh), 121.3 (CHimidazole), 120.8
(CHimidazole), 98.4 (CHCOD), 98.6 (CHCOD), 98.5 (CHCOD), 69.9 (CHCOD),
69.7 (CHCOD), 69.6 (CHCOD), 69.4 (CHCOD), 54.7 (CH2), 52.8 (CH2), 32.9
(CH2,COD), 32.9 (CH2,COD), 29.2 (CH2,COD); elemental analysis calcd (%)
for C35H32N2BrRhCHCl3 (782.8291): C 55.23, H 4.24, N 3.57; found: C
55.27, H 4.15, N 3.29; ESI-MS (cone 20 V): m/z: 583.2 [MÀBr]+.
Synthesis of complex 7: A mixture of 3 (80.0 mg, 0.10 mmol),
[{IrCl(COD)}2] (64.5 mg, 0.10 mmol), K2CO3 (82.94 mg, 0.6 mmol) and
KBr (70 mg) in THF/DMF (10:3 mL) was stirred at 758C for 8 h
under N2. The resulting suspension was cooled to room tempera-
ture and the solvent was removed under vacuum. The crude prod-
uct was purified by column chromatography. The pure compound
7 was eluted with dichloromethane/ethyl acetate (8:2) and precipi-
tated in a mixture of dichloromethane/hexane to give a yellow
solid. Yield 90 mg (65%); 1H NMR (300 MHz, CDCl3): d=8.48 (dd,
2J(H,H)=9.3, 3.2 Hz, 2H; CHpyr), 8.23–8.13 (m, 8H; CHpyr), 8.09–7.98
(m, 8H; CHpyr), 7.43 (s, 4H; CHPh), 6.58 (m, 4H; CHimidazole, CH2), 6.44
(d, 2J(H,H)=8.0 Hz, 2H; CHimidazole), 6.14 (m, 2H; CH2), 5.85 (dd,
Preparation of 6-rGO: rGO (150 mg) and CH2Cl2 (10 mL) were
added to a round-bottom flask and the suspension was sonicated
for 30 min. Compound 6 (20 mg) was then added and the mixture
was stirred at room temperature for 12 h until the solution
became clear. The black solid was filtered and washed with CH2Cl2
(225 mL) to afford 6-rGO as a black solid. The filtrates were com-
bined and evaporated to dryness under reduced pressure to give
2
2J(H,H)=14.6, 11.0 Hz, 2H; CH2), 5.59 (dd, J(H,H)=15.1, 9.5 Hz, 2H;
CH2), 4.80 (s, 4H; CHCOD), 3.18 (s, 2H; CHCOD), 3.06 (s, 2H; CHCOD),
2.12 (m, 8H; CH2,COD), 1.72 (m, 8H; CH2,COD), 1.48 ppm (m, 8H;
CH2,COD); 13C NMR (75 MHz, CDCl3): d 180.8 (IrCcarbene), 136.3 (Pyr),
131.6 (Pyr), 131.2 (Pyr), 130.7 (Pyr), 129.4 (Pyr), 128.7 (Pyr), 128.4
(Pyr), 127.9 (Pyr), 127.57 (Pyr), 127.23 (Pyr), 126.2 (CPh), 125.6 (CHPh),
124.8(CHimidazole), 124.5, (Pyr), 123.0 (CHimidazole), 120.6(Pyr), 120.1
(Pyr), 84.8 (CHCOD), 84.6 (CHCOD), 54.0 (CH2), 53.0 (CH2,COD), 52.6
(CH2,COD), 52.2 (CH2), 33.3 (CH2,COD), 29.7 ppm (CH2,COD); elemental
analysis calcd (%) for C64H58N4Br2Ir23CHCl3 (1904.9247): C 42.87, H
3.28, N 2.90.; found: C 42.56, H 2.75, N 3.14; ESI-MS (cone 20 V): m/
z: 1347 [MÀBr]+.
Synthesis of 8: A mixture of 4 (80.0 mg, 0.09 mmol), [{IrCl(COD)}2]
(67.17 mg, 0.09 mmol), K2CO3 (82.94 mg, 0.6 mmol) and KBr
(70 mg) in THF/DMF (10:3 mL) was stirred at 758C for 8 h under N2.
The resulting suspension was cooled to room temperature and the
solvent was removed under vacuum. The crude product was puri-
1
unsupported compound 6, which was analysed by H NMR using
anisole as the internal standard. Integration of the characteristic
signal of anisole (-OMe) versus CH2-pyrene revealed the amount of
complex that was deposited on the rGO. The exact amount of
complex supported was determined by ICP-MS analysis.
Preparation of 7-rGO: rGO (240 mg) and CH2Cl2 (10 mL) were
added to a round-bottomed flask and the suspension was sonicat-
ed for 30 min. Compound 7 (27 mg) was then added and the mix-
ture was stirred at room temperature for 12 h until the solution
became clear. The black solid was filtered and washed with CH2Cl2
(225 mL) to afford 7-rGO as a black solid. The filtrates were com-
bined and evaporated to dryness under reduced pressure to give
1
unsupported compound 7, which was analysed by H NMR using
Chem. Eur. J. 2015, 21, 15263 – 15271
15270
ꢀ 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim